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What is an appropriate dose of voriconazole for treatment of aspergillosis 
in African grey parrots? 
 
Clinical scenario  
 
An African grey parrot (Psittacus erithacus) is presented to your practice with severe 
dyspnoea, inappetence and loss of body condition. Following a diagnostic workup, 
aspergillosis of the air-sacs is diagnosed. Itraconazole (Fungitraxx 10 mg/ml oral solution for 
ornamental birds, Pet Life International Ltd, UK) is licensed for the treatment of aspergillosis 
in birds, but itraconazole toxicity has been reported in this species. Voriconazole (various 
manufacturers) is an alternative antifungal agent, not licensed for use in veterinary species, 
that can be prescribed under the Cascade. You wonder what the most appropriate dose would 
be to treat this parrot.  
 
The question 
 
 In [an African grey parrot with aspergillosis] is [low dose voriconazole (6mg/kg)] or [high 
dose voriconazole (10-18mg/kg)] more appropriate [for treatment of aspergillosis]? 
 
Search parameters  
 
The search terms  
 
Aspergillus OR aspergillosis OR mycoses OR mycosis  
 
AND  
 
African grey parrot' OR 'African gray parrot' OR 'African grey parrots' OR 'African gray 
parrots' OR ‘Timneh grey parrot’ OR 'Psittacus erithacus' OR 'Psittacus erithacus timneh' OR 
'Psittacus timneh'  
 
AND  
 
Voriconazole 
 
Search outcome   
 
Two relevant papers found in CAB Abstracts search 
  
One relevant paper found in Medline search 
 
Two relevant papers from both Medline and CAB.  
 
Search last performed  
 
December 7, 2017  
Summary of evidence 
 
Paper 1: Pharmacokinetics of voriconazole after oral administration of single and multiple 
doses in African grey parrots (Psittacus erithacus timneh) (Flammer et al. 2008). 
 Patient group: Healthy Timneh African grey parrots (n=20), assigned into one of two groups. 
Group One received single doses at Day 0 of 6 mg, 12 mg and 18 mg/kg voriconazole orally 
(n=12), either mixed with water or with a commercial suspending agent. Single doses were 
repeated with the same individuals 14 or 21 days after each previous dose. Group Two 
received multiple doses of 18 mg/kg voriconazole (PO q 12h) mixed with a commercial 
suspending agent for nine days (n=6). A control group (n=2) received tap water (equivalent 
volume, PO q 12h for nine days).  
 
Study type: Non-randomised, controlled trial 
 
Outcomes: Plasma samples were collected at 30 minutes and one, six, 12 and 24 hours after 
drug administration for the single dose trials. Pooling of data points produced a mean plasma 
concentration of voriconazole which was used for pharmacokinetic analysis. For the multi-
dose trial, plasma samples were collected twice for measurement of the trough plasma 
concentration (lowest concentration of voriconazole reached prior to the next dose being 
administered).  
 
Key results: Increases in the dose of voriconazole resulted in disproportional increases in 
maximum concentration of the drug in plasma. Plasma half-life of voriconazole was short 
(1.1 to 1.6 hours). The use of a commercial suspending agent increased both the Area Under 
Curve (AUC) and maximum concentration of voriconazole compared to mixing the drug with 
water. Polyuria was more severe in the treatment groups than the control group.  
 
Study Weaknesses: This study used a small sample size of healthy animals and a small 
control group and was non-randomised. Pharmacokinetics of voriconazole are dose-
dependent, therefore it is not possible to accurately extrapolate plasma concentrations of 
different doses. There may be an induction of metabolism effect of voriconazole 
administration in African grey parrots, where recurrent administration stimulates the hepatic 
enzymes that metabolise the drug. The single dose group received subsequent single doses 14 
days or 21 days after the first dose, which may have affected drug clearance. The 
investigators were not blinded to the treatment but acknowledge this in the paper. The single 
dose trial plasma measurements at 24 hours post-administration were all excluded because of 
inconsistencies in the data.  
 
FLAMMER, K., NETTIFEE OSBORNE, J.A., WEBB, D.J., FOSTER, L.E., DILLARD, 
S.L. & DAVIS, J.L. (2008) Pharmacokinetics of voriconazole after oral administration of 
single and multiple doses in African grey parrots (Psittacus erithacus timneh). American 
Journal of Veterinary Research 69, 114 -121 
 
Paper 2: Evaluation of the influence of formulation, food intake and species on voriconazole 
plasma concentration in birds (Burhenne & Scope 2012). 
 
Patient group: Clinically healthy, adult Congo African grey parrots (Psittacus erithacus). 
Experiment One: effect of food on voriconazole absorption trial. On Day One, after overnight 
fasting, parrots (n=12) were orally administered a single dose of 10 mg/kg voriconazole. On 
Day Five, the same parrots were administered, by gavage, another single dose of 10 mg/kg 
voriconazole administered in combination with food. Experiment Two: African grey parrots 
(n=17) were administered a single dose of 10 mg/kg voriconazole suspended in water, orally. 
 
Study type: Non-randomised, non-controlled trial. 
 
Outcomes: Experiment One: Blood was sampled to measure concentration of voriconazole at 
30 minutes, 60 minutes, 90 minutes, three, six and 12 hours after drug administration. 
Experiment Two: Plasma concentration of voriconazole was measured once per bird, 90 
minutes after administration. 
 
Key results: Experiment One: Plasma concentrations of voriconazole 90 minutes after 
administration were not significantly different between fasted (1.75 ± 1.40 μg/ml) and not 
fasted parrots (1.72 ± 0.36 μg/ml). Experiment Two: mean plasma concentration of 
voriconazole in African grey parrots 90 minutes after oral administration was 1.6 μg/ml.  
 
Study Weaknesses: This study used a small sample size of healthy animals with no control 
group and was non-randomised. The authors don’t state whether the parrots used in 
Experiment One are the same animals used in Experiment Two. The authors don’t state what 
medium the voriconazole was suspended in for Experiment One. Both experiments in this 
study were single dose trials, which may not be representative of the pharmacokinetics of 
voriconazole after multiple doses. 
 
BURHENNE, J. & SCOPE, A. (2012) Evaluation of the influence of formulation, food intake 
and species on voriconazole plasma concentration in birds. Veterinary Medicine Austria 99, 
157-162 
 
Comments  
 
A Minimum Inhibitory Concentration (MIC) of 0.38 μg/ml voriconazole has been reported 
for Aspergillus infections cultured from falcons (Silvanose and others 2006). Both low dose 
(6 mg/kg) and high dose (10-18 mg/kg) treatments in these studies achieved maximal 
concentrations exceeding 0.38 μg/ml. Trough plasma concentrations were maintained above 
MIC for approximately 10 hours in the single dose 10 mg/kg and 12 mg/kg trials and 12 
hours for the single dose 18 mg/kg trial. Due to a possible induction of metabolism effect, the 
multiple dose 18 mg/kg trough plasma concentration was lower than the single dose.  Both 
these studies were carried out on healthy birds over a short time frame. It is possible that the 
pharmacokinetics of voriconazole will be different in parrots with aspergillosis, as well as 
with extended treatments, One of the studies was carried out on Timneh African grey parrots 
and the other on Congo African grey parrots. The Timneh African grey parrot was previously 
considered a conspecific to the Congo African grey parrot but is now considered a separate 
species (Psittacus timneh). Further work is needed to more accurately identify the doses of 
voriconazole needed to treat African grey parrots with aspergillus infections.  
 
Bottom line 
 
10 -18 mg/kg twice daily is a reasonable dose for administration of voriconazole to African 
grey parrots infected with aspergillosis. Using a commercial suspending agent, rather than 
just mixing in water, may greatly increase the bioavailability of the drug. More research is 
needed to determine the optimum duration of treatment. It is not necessary to give the drug 
with or without food.  
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